PH
69
2
HCA
50
2
FLS
67
2
HD
35
4
DUK
47
2
IR
71
-12
MCHP
58
3
RRC
68
3
APA
32
2
MLM
72
2
KEY
53
2
WU
52
10
DO
69
9
AAL
41
2
TROW
58
2
CINF
53
2
APH
73
2
HPQ
67
4
MSI
57
13
CLX
46
2
PH
69
2
HCA
50
2
FLS
67
2
HD
35
4
DUK
47
2
IR
71
-12
MCHP
58
3
RRC
68
3
APA
32
2
MLM
72
2
KEY
53
2
WU
52
10
DO
69
9
AAL
41
2
TROW
58
2
CINF
53
2
APH
73
2
HPQ
67
4
MSI
57
13
CLX
46
2
Financhill
Back

Appili Therapeutics 10K Form

Sell
41

APLIF
Appili Therapeutics

Last Price:
0.03
Seasonality Move:
-8.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive APLIF News And Ratings

See the #1 stock for the next 7 days that we like better than APLIF

APLIF Financial Statistics

Sales & Book Value

Annual Sales: $252.77K
Cash Flow: $210.2K
Price / Cash Flow: 0
Annual Sales: $-0.06
Price / Book: 0

Profitability

EPS (TTM): -0.03060
Net Income (TTM): $-3.96M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -225.23%

Appili Therapeutics Earnings Forecast

Key Appili Therapeutics Financial Ratios

  • The Research & Development expenses have been 1,140.02% of Revenue.
  • The Interest Expense is -11.86% of Operating Income.
  • The Net Earning history of APLIF is -2,765.88% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Appili Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: APLIF
Website: appilitherapeutics.com

Debt

Debt-to-Equity Ratio: -0.81
Current Ratio: 0.46
Quick Ratio: 0.41

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APLIF Technical Analysis vs Fundamental Analysis

Sell
41
Appili Therapeutics (APLIF) is a Sell

Is Appili Therapeutics a Buy or a Sell?